Ted Feldman, MD
, has a national reputation of treating the most difficult cardiac patients.  On the forefront of emerging clinical developments and new technologies, Dr. Feldman offers hope to patients often deemed nonoperable or unmanageable with conventional catheter approaches. He is a national leader in research in percutaneous, non-surgical treatment of intracardiac shunts for stroke and migraine headache and is renowned for his use of stents in patients with no options or whose only option has been open heart surgery. Dr. Feldman was also the first physician in the U.S. to use any method for repairing malfunctioning mitral valves non-surgically in patients.

Timothy Sanborn, MD, arrived at Evanston Hospital in 2000, since then he has pioneered advanced cardiac catheterization techniques in the U. S. including treatment of cardiogenic shock and gene therapy to stimulate growth of new blood vessels. He is recognized as a pioneer in the development of arterial access closure devices.

Michael H. Salinger, MD, serves as Director of the Comprehensive Care Center and as Director of Interventional Cardiology for NorthShore University HealthSystem. He has a broad range of clinical areas of expertise including catheterization, angioplasty, stents, shunt closure, peripheral vascular disease & carotid stenting and critical care medicine.

Susan Rubin, MD, is Director of the Women’s Neurology Center at Glenbrook Hospital. She is Co-principle Investigator in the current clinical trial: Effect of Septal Closure of Atrial PFO on Events of Migraine with Premere: Escape Migraine Trial.

John C. Alexander, MD, is Head of Cardiothoracic Surgery for NorthShore University HealthSystem. He is among the leadership of the cardiovascular care team which is comprised of internationally renowned heart specialists, including clinical cardiologists, interventional cardiologists, electrophysiologists, and cardiothoracic surgeons.

× Alternate Text